PHASE-I AND PHASE-II STUDY OF FLUDARABINE PHOSPHATE IN LEUKEMIA - THERAPEUTIC EFFICACY WITH DELAYED CENTRAL-NERVOUS-SYSTEM TOXICITY

被引:169
作者
WARRELL, RP
BERMAN, E
机构
[1] MEM SLOAN KETTERING CANC CTR,HEMATOL LYMPHOMA SERV,NEW YORK,NY 10021
[2] CORNELL UNIV,MED CTR,NEW YORK,NY 10021
关键词
D O I
10.1200/JCO.1986.4.1.74
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:74 / 79
页数:6
相关论文
共 37 条
[1]  
AVRAMIS VI, 1982, CANCER RES, V42, P2587
[2]  
BLUMENREICH MS, 1984, CANCER RES, V44, P2203
[3]  
BREITHAUPT H, 1982, CANCER, V50, P1248, DOI 10.1002/1097-0142(19821001)50:7<1248::AID-CNCR2820500705>3.0.CO
[4]  
2-5
[5]  
BREUER AC, 1977, CANCER, V40, P2817, DOI 10.1002/1097-0142(197712)40:6<2817::AID-CNCR2820400611>3.0.CO
[6]  
2-V
[7]  
BRINK JJ, 1964, CANCER RES, V24, P1042
[8]  
BROCKMAN RW, 1980, CANCER RES, V40, P3610
[9]   BIOLOGIC ACTIVITY OF 9-BETA-D-ARABINOFURANOSYL-2-FLUOROADENINE - METABOLICALLY STABLE ANALOG OF 9-BETA-D-ARABINOFURANOSYLADENINE [J].
BROCKMAN, RW ;
SCHABEL, FM ;
MONTGOMERY, JA .
BIOCHEMICAL PHARMACOLOGY, 1977, 26 (22) :2193-2196
[10]  
CASPER ES, 1984, P AM ASSOC CANC RES, V25, P203